SELLAS to present preclinical SLS009 data at 2026 AACR pancreatic conference
SELLAS Life Sciences will present preclinical data on SLS009 (tambiciclib) at the 2026 AACR Conference on Pancreatic Cancer.
Three posters to highlight preclinical activity of SLS009 (tambiciclib) across patient-derived KRAS mutant organoid models of pancreatic cancer —- Studies conducted in collaboration with the University of Wisconsin School of Medicine and Public Health -NEW YORK, Sept.
02, 2026 (GLOBE NEWSWIRE…